Management of Tis, T1, and T2 squamous cell carcinoma of the glottic larynx.
Mendenhall
W M
WM
Department of Radiation Oncology, University of Florida College of Medicine, Gainesville 32610-0385.
Parsons
J T
JT
Stringer
S P
SP
Cassisi
N J
NJ
D002278:Carcinoma in Situ / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D005931:Glottis; D006801:Humans; D007822:Laryngeal Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D007825:Laryngectomy; D053685:Laser Therapy; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D011832:Radiation Injuries / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D011879:Radiotherapy Dosage; D015996:Survival Rate; D013997:Time Factors; D014827:Vocal Cords